Loading…
Health-seeking pathway of drug-resistant TB patients in Vadodara, India
BACKGROUND: Health-seeking behaviour refers to patients' choices regarding their preferred healthcare destination and the timing of seeking assistance for treatment. Patients with TB usually first approach the private sector and/or lose several months' time in inappropriate diagnosis and t...
Saved in:
Published in: | Public health action 2023-12, Vol.13 (4), p.155-161 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | BACKGROUND: Health-seeking behaviour refers to patients' choices regarding their preferred healthcare destination and the timing of seeking assistance for treatment. Patients with TB usually first approach the private sector and/or lose several months' time in inappropriate
diagnosis and treatment due to lack of awareness regarding the availability of standard treatment protocols. This can lead to poor outcomes such as drug-resistant TB (DR-TB) and/or death.METHODOLOGY: A cross-sectional study was conducted to examine the health-seeking pathway and
delays in diagnosis and initiation of DR-TB treatment among patients registered with the DR-TB centre in Vadodara District (India).RESULTS: A total of 93 patients were enrolled in the study; the median age was 35 years (IQR 24-45). For the first visit, 59 (63%) patients chose
a public healthcare facility, mainly because the facility was near their residence (n = 20, 21.5%). The median delay in reaching the first healthcare facility was 12 days (IQR 7.5-30). Delay in reaching second- and third-level care was respectively 25 days (IQR 9-68) and
16 days (IQR 4-67).CONCLUSION: Two-thirds of patients required visits to a second healthcare centre for diagnosis, while one third needed a third visit. The overall median delay for reaching the DR-TB centre was 60 days (IQR 26-122). The median duration from symptom
onset to the first healthcare contact fell within the timeframe for screening symptoms in standard diagnosis. |
---|---|
ISSN: | 2220-8372 2220-8372 |
DOI: | 10.5588/pha.23.0019 |